Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

KidneyCure

KidneyCure
2009 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$4M LATEST DEAL AMOUNT
5 INVESTORS
Description

Owner and operator of a regenerative medicine company developing cell-based therapies. The company conducts testing and research of cell technology to derive human renal stem for the treatment of renal diseases.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 9 Ahad Ha'am St.
  • P.O.B 29866
  • Tel Aviv 6129801
  • Israel

+972 00-000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore KidneyCure’s full profile, request a free trial.

KidneyCure Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 18-Nov-2018 $4M 000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

KidneyCure Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Aurum Ventures MKI Venture Capital Minority 000 0000 000000 0
Gilad Altshuler Angel (individual) Minority 000 0000 000000 0
IDI Direct Insurance Corporation Minority 000 0000 000000 0
John Finberg Angel (individual) Minority 000 0000 000000 0
Jonathan Leitersdorf Angel (individual) Minority 000 0000 000000 0

KidneyCure Executive Team (3)

Name Title Board
Seat
Contact
Info
Alon Yaar Chief Executive Officer
Benjamin Dekel MD Co-Founder
Orit Harari-Steinberg Ph.D Co-Founder

KidneyCure Board Members (1)

Name Representing Role Since Contact
Info
Oded Ben-Joseph Ph.D Self Board Member 000 0000